10,944
Total Claims
$2.2M
Drug Cost
1,756
Beneficiaries
$1,234
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-19%
Cost per patient vs peers
$1,234 vs $1,524 avg
+19%
Brand preference vs peers
16.2% vs 13.7% avg
Brand vs Generic
84% generic
Brand: 1,776 claims · $1.9M
Generic: 9,168 claims · $278K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 770 | $943K |
| Rivaroxaban | 139 | $175K |
| Evolocumab | 195 | $168K |
| Empagliflozin | 108 | $151K |
| Sacubitril/Valsartan | 89 | $131K |
| Alirocumab | 81 | $72K |
| Semaglutide | 57 | $62K |
| Dulaglutide | 33 | $52K |
| Atorvastatin Calcium | 1,989 | $39K |
| Ezetimibe | 316 | $27K |
| Ivabradine Hcl | 19 | $26K |
| Icosapent Ethyl | 46 | $23K |
| Amiodarone Hcl | 273 | $22K |
| Ticagrelor | 17 | $16K |
| Metoprolol Succinate | 713 | $16K |
Prescribing Profile
Patient Profile
74
Avg Age
50%
Female
1.45
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data